Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Julphar
Chubb
Covington
Cantor Fitzgerald
Queensland Health
Mallinckrodt
Boehringer Ingelheim
Harvard Business School

Generated: June 20, 2018

DrugPatentWatch Database Preview

Iodohippurate sodium i-131 - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for iodohippurate sodium i-131 and what is the scope of iodohippurate sodium i-131 patent protection?

Iodohippurate sodium i-131
is the generic ingredient in three branded drugs marketed by Mallinckrodt, Bracco, and Pharmalucence, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

Summary for iodohippurate sodium i-131
US Patents:0
Tradenames:3
Applicants:3
NDAs:3
Clinical Trials: 2,428
Formulation / Manufacturing:see details
DailyMed Link:iodohippurate sodium i-131 at DailyMed

US Patents and Regulatory Information for iodohippurate sodium i-131

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmalucence IODOHIPPURATE SODIUM I 131 iodohippurate sodium i-131 INJECTABLE;INJECTION 017313-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bracco HIPPUTOPE iodohippurate sodium i-131 INJECTABLE;INJECTION 015419-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mallinckrodt HIPPURAN I 131 iodohippurate sodium i-131 INJECTABLE;INJECTION 016666-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Federal Trade Commission
US Department of Justice
Queensland Health
Cerilliant
Argus Health
Cipla
Dow
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.